This statement by Dr Recknor is very bothersome:
Post# of 148288
(Total Views: 582)
Posted On: 10/06/2021 7:25:16 AM
This statement by Dr Recknor is very bothersome:
50. This means that the studies will experience a gap in monitoring and may not be useable for FDA approval.
I can't imagine what that would do to future investors interest in putting money at risk.
The Brazil trials must be positive.
50. This means that the studies will experience a gap in monitoring and may not be useable for FDA approval.
I can't imagine what that would do to future investors interest in putting money at risk.
The Brazil trials must be positive.
(3)
(3)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼